Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Docatone
2. Dopram
3. Doxapram
4. Hydrochloride, Doxapram
1. 113-07-5
2. Stimulexin
3. Dopram
4. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Monohydrochloride
5. Doxapram Hydrochloride Anhydrous
6. Doxapram (hydrochloride)
7. Fb8713u6dm
8. 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrochloride
9. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride
10. Dsstox_cid_27815
11. Dsstox_rid_82579
12. Dsstox_gsid_47837
13. Doxapramhydrochloride
14. Chebi:59837
15. Ahr-619
16. Cas-113-07-5
17. 3,3-diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone Hydrochloride
18. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Hydrochloride Hydrate
19. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride, Monohydrate
20. Ncgc00167459-01
21. Unii-fb8713u6dm
22. Einecs 204-022-3
23. 2-pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, Monohydrochloride
24. Schembl40645
25. Mls001424142
26. Chembl1200876
27. Dtxsid9047837
28. Tox21_112463
29. Mfcd00072148
30. Nsc170958
31. Akos015906444
32. Tox21_112463_1
33. Ac-4694
34. Ccg-101076
35. Ccg-221205
36. Nc00326
37. Nsc 170958
38. Sb18933
39. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride
40. Ncgc00167459-02
41. As-13336
42. Smr000469229
43. 2-pyrrolidinone,3-diphenyl-, Monohydrochloride
44. 081d530
45. 113d075
46. J-002892
47. Q27126918
48. 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one Hydrochloride
49. (+/-)-1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone Monohydrochloride
50. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Hydrochloride, Hydrate (1:1:1)
51. 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, Monohydrochloride, (+/-)-
Molecular Weight | 415.0 g/mol |
---|---|
Molecular Formula | C24H31ClN2O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 414.2074059 g/mol |
Monoisotopic Mass | 414.2074059 g/mol |
Topological Polar Surface Area | 32.8 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 487 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Doxapram hydrochloride |
Drug Label | DOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP .................................... |
Active Ingredient | Doxapram hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml |
Market Status | Prescription |
Company | Bedford |
2 of 2 | |
---|---|
Drug Name | Doxapram hydrochloride |
Drug Label | DOPRAM Injection (doxapram hydrochloride injection, USP) is a clear, colorless, sterile, non-pyrogenic, aqueous solution with pH 3.5 to 5, for intravenous administration.Each 1 mL contains:Doxapram Hydrochloride, USP .................................... |
Active Ingredient | Doxapram hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml |
Market Status | Prescription |
Company | Bedford |
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
Respiratory System Agents
Drugs used for their effects on the respiratory system. (See all compounds classified as Respiratory System Agents.)
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-06-11
Pay. Date : 2018-01-26
DMF Number : 32049
Submission : 2018-01-26
Status : Active
Type : II
Certificate Number : R1-CEP 2017-084 - Rev 00
Issue Date : 2023-07-17
Type : Chemical
Substance Number : 1201
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33794
Submission : 2019-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6114
Submission : 1985-12-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7183
Submission : 1987-10-14
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 573
Submission : 1963-06-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0223
Address of the Firm :
NDC Package Code : 10920-601
Start Marketing Date : 2017-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0223
Address of the Firm : Plot B-1 Wagle Industrial Eastate Thane W 400604 Maharashtra State
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Doxapram Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxapram Hydrochloride, including repackagers and relabelers. The FDA regulates Doxapram Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxapram Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxapram Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxapram Hydrochloride supplier is an individual or a company that provides Doxapram Hydrochloride active pharmaceutical ingredient (API) or Doxapram Hydrochloride finished formulations upon request. The Doxapram Hydrochloride suppliers may include Doxapram Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Doxapram Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxapram Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxapram Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Doxapram Hydrochloride DMFs exist exist since differing nations have different regulations, such as Doxapram Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Doxapram Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Doxapram Hydrochloride USDMF includes data on Doxapram Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxapram Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Doxapram Hydrochloride suppliers with USDMF on PharmaCompass.
A Doxapram Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Doxapram Hydrochloride Certificate of Suitability (COS). The purpose of a Doxapram Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Doxapram Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Doxapram Hydrochloride to their clients by showing that a Doxapram Hydrochloride CEP has been issued for it. The manufacturer submits a Doxapram Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Doxapram Hydrochloride CEP holder for the record. Additionally, the data presented in the Doxapram Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Doxapram Hydrochloride DMF.
A Doxapram Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Doxapram Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Doxapram Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Doxapram Hydrochloride written confirmation (Doxapram Hydrochloride WC) is an official document issued by a regulatory agency to a Doxapram Hydrochloride manufacturer, verifying that the manufacturing facility of a Doxapram Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxapram Hydrochloride APIs or Doxapram Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxapram Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Doxapram Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxapram Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxapram Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxapram Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxapram Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxapram Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxapram Hydrochloride suppliers with NDC on PharmaCompass.
Doxapram Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxapram Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxapram Hydrochloride GMP manufacturer or Doxapram Hydrochloride GMP API supplier for your needs.
A Doxapram Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Doxapram Hydrochloride's compliance with Doxapram Hydrochloride specifications and serves as a tool for batch-level quality control.
Doxapram Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Doxapram Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxapram Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxapram Hydrochloride EP), Doxapram Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxapram Hydrochloride USP).
LOOKING FOR A SUPPLIER?